Navigation Links
Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009

KUALA LUMPUR, Malaysia, Aug. 21 /PRNewswire/ -- The current economic downturn has contributed to a significant shift in the Healthcare industry, but not for Malaysia.


Nitin Naik, Vice President of the Healthcare, Asia Pacific says that the total Healthcare Expenditure grew at 13.70% CAGR from 2003 to 2008, which stood at US$ 7.6 billion in 2008 (up from US$ 4 billion in 2003). Healthcare expenditure in Malaysia is increasing driven by increased privatization within the healthcare service provision and upgrading of existing healthcare infrastructure within the public sector. The market for healthcare services has also received positive impetus from the growing promotion of health tourism and development activities.

"In particular the Diagnostics market in Malaysia stands at CAGR of 10.5% with expenditure allocations of USD45mil if judged against the other neighborhood country such as Singapore, with CAGR of 5.5% and expenditure allocations of USD24mil," he further comments.

Three of the segments that make up over 60% of the total diagnostics market are Immuno-Chemistry, Clinical Chemistry and Self Monitoring Blood Glucose (SMBG). The growing demand of SMBG devices is due to the increasing ageing population in many Asian countries and prevalence of diabetes. Most of the segments are expected to grow fairly due to emerging focus on preventative medicines in Asia.

Naik elaborates that, to further compliment the diagnostics market "diagnostics companies are expanding and combining expertise to allow respective companies to make significant contributions to diagnostics and patient care. Oncology companies are coming together to move to the forefront of diagnostics technology and to provide full range of solutions between diagnostics and therapy. With this, Molecular Diagnostics companies are able to join their cutting edge, life saving technologies and superior customer service through alliances while complementing automated diagnostics solutions for hospitals to provide clinicians with quicker and more accurate results."

Advancement in technology has also enhanced the future trend of the diagnostics market via the implementation of Nanotechnology, Molecular and Gene-based Diagnostic, Information Technology, Artificial Organs and Tissue Engineering. The technological advancement will bring several benefits in various aspects to patients by improving affordability, user friendly, long term monitoring, self testing and cater to specialized needs of individual patients' health situation.

Surviving in this dynamic diagnostics market, there are some restraining factors that would affect the market from growing as planned. Some of the restraining factors that should be taken into consideration would be low level of Research & Development from local manufacturers, lack of awareness by health professionals, lack of universal connectivity, industry consolidation suppress and passive public involvement.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit

    Emmie Kaur
    Corporate Communications -Healthcare, Asia Pacific
    DID: +603 6204 5913

    Jasminder Kaur
    Corporate Communications -Healthcare, Asia Pacific
    DID: +65 6890 0937

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan: Medico Legal Implications Related to the Usage of Electronic Health Record
2. Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
3. Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market
4. Outsourcing of IT Requirements by Healthcare Organisations Promotes All-Round Benefits, Says Frost & Sullivan
5. Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009
6. Radiology Informatics: Frost & Sullivan Examines the Next Big Wave in Medicine
7. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
8. Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market
9. Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market
10. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential
11. Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan
Post Your Comments:
(Date:11/30/2015)... ... ... Stress, anxiety, illness, infection or even a need for eyeglasses can sometimes ... MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, Florida, said ... , “Bad headaches that don’t go away, that don’t have any other reason, ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum ... summer, ushering in a new era of publicly accessible automated technology. Now, by ... continue to offer guests an up-close look at the shuttle at MOSI’s main ...
(Date:11/30/2015)... Angeles, CA (PRWEB) , ... November 30, 2015 , ... ... does matters of personal styling. So why is it a national news story when ... according to Parsa Mohebi, M.D., because appearances count more than anyone wants to admit ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive ... TX, on January 29 and 30, 2016. The course welcomes dental professionals and ... practices, to learn how to better succeed in the modern dental marketplace. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel ... bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the ... study showed that small molecule analogs that target the functions of SecA, a ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 ... the "Orphan Drugs Market 2015-2019" report ... has announced the addition of the "Orphan ... --> Research and Markets ( ... "Orphan Drugs Market 2015-2019" report to their ...
(Date:11/30/2015)... 30, 2015  IBA Molecular North America, Inc. (IBAMNA), ... radiopharmaceuticals, announced that as of January 1, 2016, it ... The decision to rebrand the company reflects a refined ... as its close relationship with Zevacor Molecular.  Both IBAMNA ... Science (IHS). Peter Burke , Vice ...
(Date:11/30/2015)... -- North America was valued at ... a CAGR of 7.6% from 2015 to 2020. --> ... in 2014, and is expected to grow at a CAGR of ... new Market Research Report "North America Cardiac Output Monitoring Devices Market ... care, others) - Analysis And Forecast To 2020", the cardiac output ...
Breaking Medicine Technology: